US tells J&J millions of vaccine doses from troubled plant can’t be used | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 04, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 04, 2025
US tells J&J millions of vaccine doses from troubled plant can’t be used

Coronavirus chronicle

BSS/AFP
12 June, 2021, 12:55 pm
Last modified: 12 June, 2021, 01:04 pm

Related News

  • Elon Musk leaving Trump administration, capping turbulent tenure
  • Touhid expresses concern over widespread rumour campaigns during meeting with USCIRF chair
  • Trump dumps Netanyahu
  • Bangladeshis in US may suffer as 5% tax proposed on sending remittances by non-citizens
  • Israeli strikes kill 146 Palestinians in Gaza in 24 hours, local health authorities say

US tells J&J millions of vaccine doses from troubled plant can’t be used

Neither the agency nor J&J revealed the precise number of doses, but The New York Times placed the number at 60 million, quoting people familiar with the matter

BSS/AFP
12 June, 2021, 12:55 pm
Last modified: 12 June, 2021, 01:04 pm
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

The US Food and Drug Administration said Friday it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can't be used because of possible contamination issues.

In a statement, the FDA said "several" batches of vaccine manufactured at the Emergent BioSolutions facility in the city of Baltimore are not suitable for use. Each batch is known to correspond to several million doses.

Neither the agency nor J&J revealed the precise number of doses, but The New York Times placed the number at 60 million, quoting people familiar with the matter.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"These actions followed an extensive review of records, including the production history of the facility and the testing performed to evaluate the quality of the product," said FDA scientist Peter Marks.

The Emergent plant was ordered to pause production in April several weeks after it was determined that batches of substance used to produce the J&J vaccine were cross-contaminated with ingredients from the AstraZeneca vaccine, ruining a reported 15 million J&J doses.

The FDA is still deciding whether to allow the factory to reopen. Sixty million AstraZeneca doses produced there and earmarked to be donated abroad are currently being inspected for quality before they can be shipped.

All of the J&J vaccines distributed and used in the United States so far were made in the Netherlands, not in Baltimore.

On the other hand, the FDA said it was greenlighting two batches of J&J vaccine made at the plant — that is to say, 10 million doses of the one-shot regimen, a source familiar with the matter said.

Additional J&J batches remain under review.

"Johnson & Johnson has committed to producing safe, high-quality vaccines in order to bring health and hope to people everywhere," said J&J executive vice president Kathy Wengel.

Meanwhile, Canada on Friday announced it would not distribute 300,000 doses of the J&J vaccine made at the Baltimore plant due to quality "concerns."

The country's health authorities planned to inspect the facility this summer.

"Until this inspection has been completed, Canada will not be accepting any product or ingredients made at this site," Health Canada said in a statement.

Top News / World+Biz

US / Johnson & Johnson / UN

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Govt eases tax burden for company funds
  • Freedom fighters in training. Photo: Courtesy
    Govt revises definition of freedom fighter, recognising physicians, nurses who treated the wounded
  • A charging port is seen on a Mercedes Benz EQC 400 4Matic electric vehicle at the Canadian International AutoShow in Toronto, Ontario, Canada, 13 February 2019. REUTERS/Mark Blinch
    Electric vehicle gets incentive package for local manufacturing

MOST VIEWED

  • Representational Image. Photo: Collected
    400 electric buses to join Dhaka’s public transport network
  • Official seal of the Government of Bangladesh
    Govt raises special incentive for employees to 15% from July
  • From left, National Citizen Party Convener Nahid Islam, BNP Standing Committee member Salahuddin Ahmed talking to reporters in Dhaka on Monday, 2 June 2025. Photos: TBS
    BNP, NCP exchange got heated during Monday's meeting with CA Yunus
  • Budget FY26: Housing sector may take a hit, flat prices set to rise
    Budget FY26: Housing sector may take a hit, flat prices set to rise
  • Pie chart showing revenue sources (NBR tax, foreign grants, etc.) and bar graph showing expenditure breakdown by sector (public services, interest payments, education, etc.) for Bangladesh's FY26 budget.
    Budget FY26 in infographics
  • Infograph: TBS
    Is the revenue target realistic?

Related News

  • Elon Musk leaving Trump administration, capping turbulent tenure
  • Touhid expresses concern over widespread rumour campaigns during meeting with USCIRF chair
  • Trump dumps Netanyahu
  • Bangladeshis in US may suffer as 5% tax proposed on sending remittances by non-citizens
  • Israeli strikes kill 146 Palestinians in Gaza in 24 hours, local health authorities say

Features

Illustration: TBS

The GOAT of all goats!

1d | Magazine
Photo: Nayem Ali

Eid-ul-Adha cattle markets

1d | Magazine
Sketch: TBS

Budget FY26: What corporate Bangladesh expects

2d | Budget
The customers in super shops are carrying their purchases in alternative bags or free paper bags. Photo: Mehedi Hasan

Super shops leading the way in polythene ban implementation

2d | Panorama

More Videos from TBS

Tesla not interested in manufacturing cars in India, big blow to Modi government

Tesla not interested in manufacturing cars in India, big blow to Modi government

10h | TBS World
What are Europe's chances of global leadership once the shadow of the United States is lifted?

What are Europe's chances of global leadership once the shadow of the United States is lifted?

1h | Others
Signs of strain in India-Canada relations

Signs of strain in India-Canada relations

12h | TBS World
What police are doing to reduce sufferings on road and to ensure safety

What police are doing to reduce sufferings on road and to ensure safety

12h | Podcast
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net